(-)-alpha-phellandrene increases expression ISO RGD:1312769 6480464 alpha phellandrene results in increased expression of CCNG2 mRNA CTD PMID:25075043 (-)-demecolcine increases expression ISO RGD:1312769 6480464 Demecolcine results in increased expression of CCNG2 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate increases expression ISO RGD:1312769 6480464 epigallocatechin gallate results in increased expression of CCNG2 mRNA CTD PMID:18851785 (1->4)-beta-D-glucan multiple interactions ISO RGD:1312770 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CCNG2 mRNA CTD PMID:36331819 (S)-nicotine increases expression ISO RGD:1312769 6480464 Nicotine results in increased expression of CCNG2 mRNA CTD PMID:23416264 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane affects expression ISO RGD:1312770 6480464 o, p'-DDT affects the expression of CCNG2 mRNA CTD PMID:18925944 1,2-dimethylhydrazine multiple interactions ISO RGD:1312770 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCNG2 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:1312770 6480464 1, 2-Dimethylhydrazine results in decreased expression of CCNG2 mRNA CTD PMID:22206623 1,4-dithiothreitol increases expression ISO RGD:1312769 6480464 Dithiothreitol results in increased expression of CCNG2 mRNA CTD PMID:17332266 14-Deoxy-11,12-didehydroandrographolide increases expression ISO RGD:1312769 6480464 14-deoxy-11, 12-didehydroandrographolide results in increased expression of CCNG2 mRNA CTD PMID:22101062 17beta-estradiol multiple interactions ISO RGD:1312769 6480464 [Estradiol binds to ESR1 protein] which results in decreased expression of CCNG2 mRNA more ... CTD PMID:19619570 , PMID:22596188 17beta-estradiol decreases expression ISO RGD:1312769 6480464 Estradiol results in decreased expression of CCNG2 mRNA CTD PMID:26865669 more ... 17beta-estradiol affects expression ISO RGD:1312769 6480464 Estradiol affects the expression of CCNG2 mRNA CTD PMID:22574217 17beta-estradiol decreases expression ISO RGD:1312770 6480464 Estradiol results in decreased expression of CCNG2 mRNA CTD PMID:14664709 17beta-estradiol affects expression ISO RGD:1312770 6480464 Estradiol affects the expression of CCNG2 mRNA CTD PMID:15598610 17beta-estradiol increases expression ISO RGD:1312769 6480464 Estradiol results in increased expression of CCNG2 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1312769 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CCNG2 mRNA] more ... CTD PMID:19574409 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CCNG2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1312770 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CCNG2 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1312769 6480464 Tetrachlorodibenzodioxin results in increased expression of CCNG2 mRNA, Tetrachlorodibenzodioxin results in increased expression of CCNG2 protein CTD PMID:19574409 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1312770 6480464 Tetrachlorodibenzodioxin affects the expression of CCNG2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CCNG2 mRNA CTD PMID:22298810 2-butoxyethanol decreases expression ISO RGD:1312770 6480464 n-butoxyethanol results in decreased expression of CCNG2 mRNA CTD PMID:19812364 2-hydroxypropanoic acid increases expression ISO RGD:1312769 6480464 Lactic Acid results in increased expression of CCNG2 mRNA CTD PMID:30851411 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1312770 6480464 tetrabromobisphenol A results in decreased expression of CCNG2 mRNA CTD PMID:25172293 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1312770 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of CCNG2 mRNA CTD PMID:26251327 3-methylcholanthrene multiple interactions ISO RGD:1312769 6480464 Methylcholanthrene promotes the reaction [AHR protein binds to CCNG2 promoter] more ... CTD PMID:20348232 3-methylcholanthrene increases expression ISO RGD:1312769 6480464 Methylcholanthrene results in increased expression of CCNG2 mRNA CTD PMID:20348232 4,4'-diaminodiphenylmethane increases expression ISO RGD:1312770 6480464 4, 4'-diaminodiphenylmethane results in increased expression of CCNG2 mRNA CTD PMID:18648102 4-hydroxynon-2-enal decreases expression ISO RGD:1312770 6480464 4-hydroxy-2-nonenal results in decreased expression of CCNG2 mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide decreases expression ISO RGD:1312770 6480464 Fenretinide results in decreased expression of CCNG2 mRNA CTD PMID:28973697 4-nitrophenol increases expression ISO RGD:1312770 6480464 4-nitrophenol results in increased expression of CCNG2 mRNA CTD PMID:34673133 5-azacytidine decreases expression ISO RGD:1312769 6480464 Azacitidine results in decreased expression of CCNG2 mRNA CTD PMID:21245298 5-fluorouracil affects response to substance ISO RGD:1312769 6480464 CCNG2 affects the susceptibility to Fluorouracil CTD PMID:15067352 5-fluorouracil decreases expression ISO RGD:1312770 6480464 Fluorouracil results in decreased expression of CCNG2 mRNA CTD PMID:19272435 5-fluorouracil increases expression ISO RGD:1312769 6480464 Fluorouracil results in increased expression of CCNG2 mRNA CTD PMID:16510598 more ... 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of CCNG2 mRNA CTD PMID:30047161 acrolein multiple interactions ISO RGD:1312769 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of CCNG2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of CCNG2 mRNA CTD PMID:32699268 acrylamide affects expression EXP 6480464 Acrylamide affects the expression of CCNG2 mRNA CTD PMID:28959563 afimoxifene multiple interactions ISO RGD:1312769 6480464 afimoxifene inhibits the reaction [Estrogens results in decreased expression of CCNG2 mRNA] CTD PMID:21233418 aflatoxin B1 affects expression ISO RGD:1312769 6480464 Aflatoxin B1 affects the expression of CCNG2 protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:1312769 6480464 Aflatoxin B1 results in decreased methylation of CCNG2 gene CTD PMID:27153756 alpha-phellandrene increases expression ISO RGD:1312769 6480464 alpha phellandrene results in increased expression of CCNG2 mRNA CTD PMID:25075043 alpha-pinene multiple interactions ISO RGD:1312769 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of CCNG2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of CCNG2 mRNA CTD PMID:32699268 amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of CCNG2 mRNA CTD PMID:30047161 antirheumatic drug increases expression ISO RGD:1312769 6480464 Antirheumatic Agents results in increased expression of CCNG2 mRNA CTD PMID:24449571 arsenous acid increases expression ISO RGD:1312769 6480464 Arsenic Trioxide results in increased expression of CCNG2 mRNA CTD PMID:20458559 more ... avobenzone increases expression ISO RGD:1312769 6480464 avobenzone results in increased expression of CCNG2 mRNA CTD PMID:31016361 beauvericin multiple interactions ISO RGD:1312769 6480464 [beauvericin co-treated with enniatins] results in decreased expression of CCNG2 mRNA CTD PMID:31100301 benzo[a]pyrene increases expression ISO RGD:1312770 6480464 Benzo(a)pyrene results in increased expression of CCNG2 mRNA CTD PMID:20504355 , PMID:22228805 benzo[a]pyrene increases expression ISO RGD:1312769 6480464 Benzo(a)pyrene results in increased expression of CCNG2 mRNA CTD PMID:30453624 benzo[a]pyrene decreases methylation ISO RGD:1312769 6480464 Benzo(a)pyrene results in decreased methylation of CCNG2 promoter CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1312769 6480464 7 more ... CTD PMID:20018196 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1312769 6480464 7 more ... CTD PMID:26238291 bicalutamide increases expression ISO RGD:1312769 6480464 bicalutamide results in increased expression of CCNG2 mRNA CTD PMID:15790403 bis(2-chloroethyl) sulfide increases expression ISO RGD:1312770 6480464 Mustard Gas results in increased expression of CCNG2 mRNA CTD PMID:15674843 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1312769 6480464 Diethylhexyl Phthalate results in increased expression of CCNG2 mRNA CTD PMID:31163220 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in decreased expression of CCNG2 mRNA CTD PMID:26496021 bisphenol A increases expression ISO RGD:1312770 6480464 bisphenol A results in increased expression of CCNG2 mRNA CTD PMID:33221593 bisphenol A increases expression ISO RGD:1312769 6480464 bisphenol A results in increased expression of CCNG2 mRNA CTD PMID:29275510 bisphenol A decreases expression ISO RGD:1312769 6480464 bisphenol A results in decreased expression of CCNG2 mRNA CTD PMID:28711546 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CCNG2 mRNA CTD PMID:25181051 more ... bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CCNG2 mRNA CTD PMID:26982218 bortezomib multiple interactions ISO RGD:1312769 6480464 [BRCA1 mutant form results in increased susceptibility to Bortezomib] which results in decreased expression of CCNG2 mRNA CTD PMID:25522274 butanal decreases expression ISO RGD:1312769 6480464 butyraldehyde results in decreased expression of CCNG2 mRNA CTD PMID:26079696 cadmium dichloride affects methylation EXP 6480464 Cadmium Chloride affects the methylation of CCNG2 promoter CTD PMID:22457795 cadmium dichloride decreases expression ISO RGD:1312769 6480464 Cadmium Chloride results in decreased expression of CCNG2 mRNA CTD PMID:25596134 calciol increases expression ISO RGD:1312770 6480464 Cholecalciferol results in increased expression of CCNG2 mRNA CTD PMID:16508948 calcitriol increases expression ISO RGD:1312769 6480464 Calcitriol results in increased expression of CCNG2 mRNA CTD PMID:16002434 carbamazepine affects expression ISO RGD:1312769 6480464 Carbamazepine affects the expression of CCNG2 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:1312769 6480464 Nanotubes, Carbon results in increased expression of CCNG2 mRNA CTD PMID:15585362 carbon nanotube decreases expression ISO RGD:1312770 6480464 Nanotubes, Carbon analog results in decreased expression of CCNG2 mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1312769 6480464 CGP 52608 promotes the reaction [RORA protein binds to CCNG2 gene] CTD PMID:28238834 chloroacetaldehyde decreases expression ISO RGD:1312769 6480464 chloroacetaldehyde results in decreased expression of CCNG2 mRNA CTD PMID:25596134 chlorohydrocarbon increases expression ISO RGD:1312769 6480464 Hydrocarbons, Chlorinated results in increased expression of CCNG2 mRNA CTD PMID:14757120 chromium(6+) affects expression ISO RGD:1312770 6480464 chromium hexavalent ion affects the expression of CCNG2 mRNA CTD PMID:28472532 cidofovir anhydrous decreases expression ISO RGD:1312769 6480464 Cidofovir results in decreased expression of CCNG2 mRNA CTD PMID:25596134 cisplatin affects response to substance ISO RGD:1312769 6480464 CCNG2 protein affects the susceptibility to Cisplatin CTD PMID:16217747 cisplatin multiple interactions ISO RGD:1312769 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of CCNG2 mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:1312769 6480464 Cisplatin results in decreased expression of CCNG2 mRNA CTD PMID:25596134 cisplatin increases expression ISO RGD:1312769 6480464 Cisplatin results in increased expression of CCNG2 mRNA CTD PMID:27594783 clodronic acid decreases expression ISO RGD:1312769 6480464 Clodronic Acid results in decreased expression of CCNG2 mRNA CTD PMID:25596134 clomiphene increases expression ISO RGD:1312769 6480464 Clomiphene results in increased expression of CCNG2 mRNA CTD PMID:26865669 cobalt dichloride multiple interactions ISO RGD:1312769 6480464 zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of CCNG2 mRNA] CTD PMID:22202117 cobalt dichloride increases expression ISO RGD:1312769 6480464 cobaltous chloride results in increased expression of CCNG2 mRNA CTD PMID:19376846 more ... copper atom multiple interactions ISO RGD:1312769 6480464 [Chelating Agents binds to Copper] which results in increased expression of CCNG2 mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RGD:1312769 6480464 [Chelating Agents binds to Copper] which results in increased expression of CCNG2 mRNA CTD PMID:30911355 copper(II) sulfate increases expression ISO RGD:1312769 6480464 Copper Sulfate results in increased expression of CCNG2 mRNA CTD PMID:19549813 coumestrol decreases expression ISO RGD:1312769 6480464 Coumestrol results in decreased expression of CCNG2 mRNA CTD PMID:19167446 cyclosporin A increases expression ISO RGD:1312769 6480464 Cyclosporine results in increased expression of CCNG2 mRNA CTD PMID:20106945 cyclosporin A decreases expression ISO RGD:1312769 6480464 Cyclosporine results in decreased expression of CCNG2 mRNA CTD PMID:25562108 more ... daunorubicin increases expression ISO RGD:1312769 6480464 Daunorubicin results in increased expression of CCNG2 mRNA CTD PMID:18754885 deoxynivalenol increases expression ISO RGD:1312769 6480464 deoxynivalenol results in increased expression of CCNG2 mRNA CTD PMID:30169763 diarsenic trioxide increases expression ISO RGD:1312769 6480464 Arsenic Trioxide results in increased expression of CCNG2 mRNA CTD PMID:20458559 more ... diazinon increases expression ISO RGD:1312769 6480464 Diazinon results in increased expression of CCNG2 mRNA CTD PMID:24356939 dicrotophos decreases expression ISO RGD:1312769 6480464 dicrotophos results in decreased expression of CCNG2 mRNA CTD PMID:28302478 Diisodecyl phthalate increases expression ISO RGD:1312770 6480464 diisodecyl phthalate results in increased expression of CCNG2 mRNA CTD PMID:25270620 dioxygen increases expression ISO RGD:1312770 6480464 Oxygen deficiency results in increased expression of CCNG2 mRNA CTD PMID:20880076 dioxygen increases expression ISO RGD:1312769 6480464 Oxygen deficiency results in increased expression of CCNG2 mRNA CTD PMID:20042640 more ... divanadium pentaoxide decreases expression ISO RGD:1312769 6480464 vanadium pentoxide results in decreased expression of CCNG2 mRNA CTD PMID:17459161 dorsomorphin multiple interactions ISO RGD:1312769 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin multiple interactions ISO RGD:1312769 6480464 Doxorubicin inhibits the reaction [NR1I3 protein results in increased expression of CCNG2 mRNA] CTD PMID:21557330 doxycycline multiple interactions ISO RGD:1312770 6480464 Doxycycline inhibits the reaction [Isoproterenol results in increased expression of CCNG2 mRNA] CTD PMID:18089841 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of CCNG2 mRNA CTD PMID:29391264 enniatin multiple interactions ISO RGD:1312769 6480464 [beauvericin co-treated with enniatins] results in decreased expression of CCNG2 mRNA CTD PMID:31100301 entinostat multiple interactions ISO RGD:1312769 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA CTD PMID:27188386 entinostat decreases expression ISO RGD:1312769 6480464 entinostat results in decreased expression of CCNG2 mRNA CTD PMID:26272509 epoxiconazole increases expression ISO RGD:1312770 6480464 epoxiconazole results in increased expression of CCNG2 mRNA CTD PMID:35436446 estrone decreases expression ISO RGD:1312769 6480464 Estrone results in decreased expression of CCNG2 mRNA CTD PMID:26865669 ethanol increases expression ISO RGD:1312769 6480464 Ethanol results in increased expression of CCNG2 mRNA CTD PMID:23378141 ethanol affects splicing ISO RGD:1312770 6480464 Ethanol affects the splicing of CCNG2 mRNA CTD PMID:30319688 ethanol multiple interactions ISO RGD:1312769 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of CCNG2 mRNA CTD PMID:23378141 ethyl methanesulfonate increases expression ISO RGD:1312769 6480464 Ethyl Methanesulfonate results in increased expression of CCNG2 mRNA CTD PMID:23649840 etoposide increases expression ISO RGD:1312769 6480464 Etoposide results in increased expression of CCNG2 mRNA CTD PMID:18754885 fenofibrate decreases expression ISO RGD:1312769 6480464 Fenofibrate results in decreased expression of CCNG2 mRNA CTD PMID:25596134 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of CCNG2 mRNA CTD PMID:25596134 fingolimod hydrochloride increases expression ISO RGD:1312769 6480464 Fingolimod Hydrochloride results in increased expression of CCNG2 mRNA CTD PMID:24356939 fluoxetine increases expression ISO RGD:1312769 6480464 Fluoxetine results in increased expression of CCNG2 mRNA CTD PMID:24356939 flusilazole affects expression ISO RGD:1312770 6480464 flusilazole affects the expression of CCNG2 mRNA CTD PMID:21195148 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of CCNG2 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1312769 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of CCNG2 mRNA CTD PMID:23378141 folic acid multiple interactions ISO RGD:1312770 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCNG2 mRNA CTD PMID:22206623 formaldehyde increases expression ISO RGD:1312769 6480464 Formaldehyde results in increased expression of CCNG2 mRNA CTD PMID:23649840 fulvestrant increases expression ISO RGD:1312769 6480464 fulvestrant results in increased expression of CCNG2 mRNA CTD PMID:26865669 gamma-hexachlorocyclohexane increases expression ISO RGD:1312769 6480464 Hexachlorocyclohexane results in increased expression of CCNG2 mRNA CTD PMID:24356939 gemcitabine increases expression ISO RGD:1312769 6480464 Gemcitabine results in increased expression of CCNG2 mRNA CTD PMID:17039268 genistein decreases expression ISO RGD:1312769 6480464 Genistein results in decreased expression of CCNG2 mRNA CTD PMID:26865669 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CCNG2 mRNA CTD PMID:22061828 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of CCNG2 mRNA CTD PMID:33387578 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of CCNG2 mRNA CTD PMID:24136188 hexaconazole affects expression ISO RGD:1312770 6480464 hexaconazole affects the expression of CCNG2 mRNA CTD PMID:21195148 hexestrol decreases expression ISO RGD:1312769 6480464 Hexestrol results in decreased expression of CCNG2 mRNA CTD PMID:26865669 hydroxyurea increases expression ISO RGD:1312770 6480464 Hydroxyurea results in increased expression of CCNG2 mRNA CTD PMID:12929121 ifosfamide decreases expression ISO RGD:1312769 6480464 Ifosfamide results in decreased expression of CCNG2 mRNA CTD PMID:25596134 Indeno[1,2,3-cd]pyrene increases expression ISO RGD:1312769 6480464 indeno(1 more ... CTD PMID:32251684 indometacin increases expression ISO RGD:1312769 6480464 Indomethacin results in increased expression of CCNG2 mRNA CTD PMID:16984733 irinotecan increases expression ISO RGD:1312769 6480464 Irinotecan analog results in increased expression of CCNG2 mRNA CTD PMID:18927307 iron atom increases expression ISO RGD:1312769 6480464 Iron deficiency results in increased expression of CCNG2 mRNA CTD PMID:20368581 iron(0) increases expression ISO RGD:1312769 6480464 Iron deficiency results in increased expression of CCNG2 mRNA CTD PMID:20368581 isoprenaline multiple interactions ISO RGD:1312770 6480464 Doxycycline inhibits the reaction [Isoproterenol results in increased expression of CCNG2 mRNA] CTD PMID:18089841 isoprenaline increases expression ISO RGD:1312770 6480464 Isoproterenol results in increased expression of CCNG2 mRNA CTD PMID:18089841 , PMID:20003209 kenpaullone decreases expression EXP 6480464 kenpaullone results in decreased expression of CCNG2 mRNA CTD PMID:17993264 L-1,4-dithiothreitol increases expression ISO RGD:1312769 6480464 Dithiothreitol results in increased expression of CCNG2 mRNA CTD PMID:17332266 lithium chloride decreases expression ISO RGD:1312769 6480464 Lithium Chloride results in decreased expression of CCNG2 mRNA CTD PMID:15711924 lithium chloride increases expression ISO RGD:1312769 6480464 Lithium Chloride results in increased expression of CCNG2 mRNA CTD PMID:17440966 mercury dibromide decreases expression ISO RGD:1312769 6480464 mercuric bromide results in decreased expression of CCNG2 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1312769 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA CTD PMID:27188386 mestranol decreases expression ISO RGD:1312769 6480464 Mestranol results in decreased expression of CCNG2 mRNA CTD PMID:26865669 metformin decreases expression EXP 6480464 Metformin results in decreased expression of CCNG2 mRNA CTD PMID:25596134 metformin multiple interactions ISO RGD:1312769 6480464 [Paclitaxel co-treated with Metformin] results in decreased expression of CCNG2 mRNA CTD PMID:29309887 metformin decreases expression ISO RGD:1312769 6480464 Metformin results in decreased expression of CCNG2 mRNA CTD PMID:25596134 methyl methanesulfonate increases expression ISO RGD:1312769 6480464 Methyl Methanesulfonate results in increased expression of CCNG2 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1312769 6480464 methylmercuric chloride results in decreased expression of CCNG2 mRNA CTD PMID:28001369 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of CCNG2 mRNA CTD PMID:28801915 neomycin increases expression ISO RGD:1312770 6480464 Neomycin results in increased expression of CCNG2 mRNA CTD PMID:30626089 nickel atom decreases expression ISO RGD:1312769 6480464 Nickel results in decreased expression of CCNG2 mRNA CTD PMID:24768652 , PMID:25583101 nickel dichloride multiple interactions ISO RGD:1312770 6480464 HIF1A affects the reaction [nickel chloride results in increased expression of CCNG2 mRNA] CTD PMID:12729255 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of CCNG2 mRNA CTD PMID:22546817 nickel dichloride increases expression ISO RGD:1312769 6480464 nickel chloride results in increased expression of CCNG2 mRNA CTD PMID:17312168 , PMID:21455298 nickel dichloride increases expression ISO RGD:1312770 6480464 nickel chloride results in increased expression of CCNG2 mRNA CTD PMID:12729255 nickel subsulfide affects expression ISO RGD:1312770 6480464 nickel subsulfide affects the expression of CCNG2 mRNA CTD PMID:12729255 niclosamide multiple interactions ISO RGD:1312769 6480464 Niclosamide inhibits the reaction [PIK3CA protein modified form results in decreased expression of CCNG2 mRNA] CTD PMID:27542212 niclosamide increases expression ISO RGD:1312769 6480464 Niclosamide results in increased expression of CCNG2 mRNA CTD PMID:36318118 nicotine increases expression ISO RGD:1312769 6480464 Nicotine results in increased expression of CCNG2 mRNA CTD PMID:23416264 nonivamide increases expression ISO RGD:1312769 6480464 nonivamide results in increased expression of CCNG2 mRNA CTD PMID:17332266 nonivamide multiple interactions ISO RGD:1312769 6480464 [nonivamide binds to and results in increased activity of TRPV1 protein] which results in increased expression of CCNG2 mRNA CTD PMID:17332266 ochratoxin A decreases expression ISO RGD:1312769 6480464 ochratoxin A results in decreased expression of CCNG2 mRNA CTD PMID:24356939 ozone multiple interactions ISO RGD:1312769 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of CCNG2 mRNA more ... CTD PMID:32699268 ozone multiple interactions ISO RGD:1312770 6480464 [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CCNG2 mRNA CTD PMID:27106289 p-anisidine increases expression ISO RGD:1312770 6480464 4-anisidine results in increased expression of CCNG2 mRNA CTD PMID:12929121 p-chloromercuribenzoic acid decreases expression ISO RGD:1312769 6480464 p-Chloromercuribenzoic Acid results in decreased expression of CCNG2 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1312769 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA CTD PMID:27188386 paclitaxel increases expression ISO RGD:1312770 6480464 Paclitaxel results in increased expression of CCNG2 mRNA CTD PMID:12929121 paclitaxel multiple interactions ISO RGD:1312769 6480464 [Paclitaxel co-treated with Metformin] results in decreased expression of CCNG2 mRNA CTD PMID:29309887 panobinostat decreases expression ISO RGD:1312769 6480464 panobinostat results in decreased expression of CCNG2 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:1312769 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA CTD PMID:27188386 paracetamol affects expression ISO RGD:1312770 6480464 Acetaminophen affects the expression of CCNG2 mRNA CTD PMID:15606129 , PMID:17562736 pentanal decreases expression ISO RGD:1312769 6480464 pentanal results in decreased expression of CCNG2 mRNA CTD PMID:26079696 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1312770 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CCNG2 mRNA CTD PMID:36331819 phenobarbital affects expression ISO RGD:1312770 6480464 Phenobarbital affects the expression of CCNG2 mRNA CTD PMID:23091169 phenylmercury acetate decreases expression ISO RGD:1312769 6480464 Phenylmercuric Acetate results in decreased expression of CCNG2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1312769 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA CTD PMID:27188386 picene increases expression ISO RGD:1312769 6480464 picene results in increased expression of CCNG2 mRNA CTD PMID:32251684 pirinixic acid multiple interactions ISO RGD:1312770 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CCNG2 mRNA, PPARA protein promotes the reaction [pirinixic acid results in increased expression of CCNG2 mRNA] CTD PMID:19710929 , PMID:20059764 pirinixic acid increases expression ISO RGD:1312770 6480464 pirinixic acid results in increased expression of CCNG2 mRNA CTD PMID:18301758 more ... prednisolone increases expression ISO RGD:1312769 6480464 Prednisolone results in increased expression of CCNG2 mRNA CTD PMID:24356939 pyrvinium multiple interactions ISO RGD:1312769 6480464 pyrvinium inhibits the reaction [PIK3CA protein modified form results in decreased expression of CCNG2 mRNA] CTD PMID:27542212 quercetin decreases expression ISO RGD:1312769 6480464 Quercetin results in decreased expression of CCNG2 mRNA CTD PMID:21632981 rac-lactic acid increases expression ISO RGD:1312769 6480464 Lactic Acid results in increased expression of CCNG2 mRNA CTD PMID:30851411 raloxifene increases expression ISO RGD:1312769 6480464 Raloxifene Hydrochloride results in increased expression of CCNG2 mRNA CTD PMID:16497877 , PMID:26865669 SB 431542 multiple interactions ISO RGD:1312769 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1312769 6480464 Silicon Dioxide analog results in decreased expression of CCNG2 mRNA CTD PMID:25895662 silver atom decreases expression ISO RGD:1312770 6480464 Silver results in decreased expression of CCNG2 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1312770 6480464 Silver results in decreased expression of CCNG2 mRNA CTD PMID:27131904 sirolimus multiple interactions ISO RGD:1312769 6480464 [cotylenin A co-treated with Sirolimus] results in increased expression of CCNG2 mRNA more ... CTD PMID:18754885 more ... sirolimus increases expression ISO RGD:1312769 6480464 Sirolimus results in increased expression of CCNG2 mRNA CTD PMID:24356939 sodium arsenite increases expression ISO RGD:1312769 6480464 sodium arsenite results in increased expression of CCNG2 mRNA CTD PMID:20886546 sodium arsenite decreases expression ISO RGD:1312769 6480464 sodium arsenite results in decreased expression of CCNG2 mRNA CTD PMID:34032870 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of CCNG2 mRNA CTD PMID:25993096 Soman decreases expression EXP 6480464 Soman results in decreased expression of CCNG2 mRNA CTD PMID:19281266 succimer multiple interactions ISO RGD:1312770 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CCNG2 mRNA CTD PMID:21641980 sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of CCNG2 mRNA CTD PMID:30047161 T-2 toxin decreases expression ISO RGD:1312769 6480464 T-2 Toxin results in decreased expression of CCNG2 mRNA CTD PMID:34581912 tert-butyl hydroperoxide decreases expression ISO RGD:1312769 6480464 tert-Butylhydroperoxide results in decreased expression of CCNG2 mRNA CTD PMID:15336504 testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in decreased expression of CCNG2 mRNA CTD PMID:26496021 tetrachloroethene increases expression ISO RGD:1312770 6480464 Tetrachloroethylene results in increased expression of CCNG2 mRNA CTD PMID:28973375 tetrachloromethane increases expression ISO RGD:1312770 6480464 Carbon Tetrachloride results in increased expression of CCNG2 mRNA CTD PMID:17484886 , PMID:31919559 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CCNG2 mRNA CTD PMID:31150632 thapsigargin increases expression ISO RGD:1312769 6480464 Thapsigargin results in increased expression of CCNG2 mRNA CTD PMID:17332266 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CCNG2 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:1312770 6480464 titanium dioxide results in decreased expression of CCNG2 mRNA CTD PMID:27760801 topotecan affects response to substance ISO RGD:1312769 6480464 CCNG2 protein affects the susceptibility to Topotecan CTD PMID:16217747 triadimefon affects expression ISO RGD:1312770 6480464 triadimefon affects the expression of CCNG2 mRNA CTD PMID:21195148 Tributyltin oxide decreases expression ISO RGD:1312770 6480464 bis(tri-n-butyltin)oxide results in decreased expression of CCNG2 mRNA CTD PMID:18958704 trichostatin A decreases expression ISO RGD:1312769 6480464 trichostatin A results in decreased expression of CCNG2 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A affects expression ISO RGD:1312769 6480464 trichostatin A affects the expression of CCNG2 mRNA CTD PMID:28542535 trichostatin A multiple interactions ISO RGD:1312769 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA CTD PMID:27188386 triclosan increases expression ISO RGD:1312769 6480464 Triclosan results in increased expression of CCNG2 mRNA CTD PMID:30510588 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of CCNG2 mRNA CTD PMID:30589522 triptonide decreases expression ISO RGD:1312770 6480464 triptonide results in decreased expression of CCNG2 mRNA CTD PMID:33045310 trovafloxacin decreases expression ISO RGD:1312770 6480464 trovafloxacin results in decreased expression of CCNG2 mRNA CTD PMID:35537566 tungsten increases expression ISO RGD:1312770 6480464 Tungsten results in increased expression of CCNG2 mRNA CTD PMID:30912803 urethane increases expression ISO RGD:1312769 6480464 Urethane results in increased expression of CCNG2 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1312770 6480464 Valproic Acid affects the expression of CCNG2 mRNA CTD PMID:17292431 valproic acid multiple interactions ISO RGD:1312769 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1312769 6480464 Valproic Acid results in decreased expression of CCNG2 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:1312769 6480464 Valproic Acid affects the expression of CCNG2 mRNA CTD PMID:25979313 zinc dichloride multiple interactions ISO RGD:1312769 6480464 zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of CCNG2 mRNA] CTD PMID:22202117
